Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Walker, Claire (2017) Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. In: UNSPECIFIED.

Full text not available from this repository.

Item Type:Conference or Workshop contribution (Poster)
Item Status:Live Archive

Divisions:College of Science
ID Code:41723
Deposited On:05 Aug 2020 12:44

Repository Staff Only: item control page